Association of Marine-Origin n-3 Polyunsaturated Fatty Acids Consumption and Functional Mobility in the Community-Dwelling Oldest Old.

M. Takayama, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582 Japan, E-mail address: , TEL: +81-3-3353-1211 (ext. 62915), FAX: +81-3-5269-2468.
The Journal of Nutrition Health and Aging (Impact Factor: 3). 01/2013; 17(1):82-9. DOI: 10.1007/s12603-012-0389-1
Source: PubMed


Objective: To examine whether habitual dietary intake of marine-origin n-3 polyunsaturated fatty acids (MOPUFA), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are associated with functional mobility in the community-dwelling oldest old, 85 years or older, who are at high risk for physical disability. Design: A cross-sectional study. Setting: A community-based survey conducted at university research center or home-based. Participants: Four hundred seventeen (189 men, 228 women) out of 542 participants in the baseline examination of the Tokyo Oldest Old Survey on Total Health, a community-based ongoing longitudinal study among the oldest old living in the center of Japan. Measurements: Habitual dietary intake of MOPUFA was assessed by the brief-type self-administered diet history questionnaire (BDHQ), and functional mobility was assessed by the Timed Up and Go test. Plasma inflammatory biomarkers (C-reactive protein, interleukin-6 and tumor necrosis factor-α) were measured. We evaluated the cross-sectional association between habitual intake of MOPUFA and functional mobility using multivariate logistic regression analysis. Prior to the analysis, validation of BDHQ in this study was confirmed among 190 participants (96 men, 94 women) based on the EPA and DHA concentrations in the erythrocyte membrane phospholipids as reference. Results: Moderate correlation between estimated dietary intake of EPA/DHA and concentration of EPA/DHA in the erythrocyte membrane phospholipids was obtained (Spearman's r=0.29-0.58, p<0.01). Multivariate logistic regression analysis revealed that a lower habitual intake of EPA+DHA was significantly associated with poor functional mobility in men but not in women (OR (95%CI) per 1 SD increase of EPA+DHA intake; 0.55 (0.33-0.91), 0.88 (0.59-1.32), men and women respectively). Conclusions: Habitual intake of MOPUFA was associated with functional mobility in community-dwelling oldest old men.

Download full-text


Available from: Michio Hashimoto, Aug 05, 2014
29 Reads
  • Source
    • "Considering that maintenance of muscle mass is a fundamental determinant of its capacity to generate force, of interest is the potential correlation between PUFAs consumption and muscle strength in the elderly. So far, inconclusive results are available [180, 181]. In particular, in 2009, a cross-sectional study found no correlation between total ω3 or ω6 PUFA intakes and muscle strength in aged Americans [180], whereas, in 2013, the Tokyo Oldest Old Survey on Total Health showed that higher consumption of EPA and DHA is significantly associated with higher functional mobility in men. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Myopathies are chronic degenerative pathologies that induce the deterioration of the structure and function of skeletal muscle. So far a definitive therapy has not yet been developed and the main aim of myopathy treatment is to slow the progression of the disease. Current nonpharmacological therapies include rehabilitation, ventilator assistance, and nutritional supplements, all of which aim to delay the onset of the disease and relieve its symptoms. Besides an adequate diet, nutritional supplements could play an important role in the treatment of myopathic patients. Here we review the most recent in vitro and in vivo studies investigating the role supplementation with creatine, L-carnitine, and ω3 PUFAs plays in myopathy treatment. Our results suggest that these dietary supplements could have beneficial effects; nevertheless continued studies are required before they could be recommended as a routine treatment in muscle diseases.
    BioMed Research International 08/2014; 2014:613890. DOI:10.1155/2014/613890 · 2.71 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Age-related bone and muscle loss are major public health problems. Investigational therapies to reduce these losses include anti-inflammatory dietary supplementations, such as polyunsaturated fatty acids (PUFA). Surprisingly, this topic has received little attention in the osteoporosis community. Recent research highlights the role of PUFA in inflammatory regulation of bone remodeling via cellular pathways. Emerging research suggests significant roles for PUFA in reducing bone and muscle loss with aging; however, findings are conflicted for PUFA and fracture risk. Limited studies suggest a relation between higher omega-3 FA and better muscle/bone in older adults. This review highlights new research since 2008 and synthesizes our current understanding of PUFA in relation to bone and muscle. Across study designs, evidence indicates that PUFA has positive effects upon bone. As data are sparse, future clinical trials and prospective studies are important to determine the long term benefits of PUFA supplementation upon bone and muscle outcomes.
    Current Osteoporosis Reports 07/2013; 11(3). DOI:10.1007/s11914-013-0149-0
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background/Objectives: Low intake of long chain polyunsaturated fatty acids (PUFAs) are associated with physical disability; however, prospective studies of circulating PUFAs are scarce. We examined associations between plasma phospholipid n−3 and n−6 PUFAs with risk of incident mobility disability and gait speed decline. Subjects/Methods: Data are from a subgroup of the Age, Gene/Environment Susceptibility–Reykjavik Study, a population-based study of risk factors for disease and disability in old age. In this subgroup (n=556, mean age 75.1±5.0 years, 47.5% men), plasma phospholipid PUFAs were assessed at baseline using gas chromatography. Mobility disability and usual gait speed were assessed at baseline and after 5.2±0.2 years. Mobility disability was defined as the following: having much difficulty, or being unable to walk 500 m or climb up 10 steps; decline in gait speed was defined as change greater than or equal to0.10 m/s. Logistic regression analyses were performed to determine associations between sex-specific s.d. increments in PUFAs with risk of incident mobility disability and gait speed decline. Odds ratios (95% confidence intervals) adjusted for demographics, follow-up time, risk factors and serum vitamin D were reported. Results: In women, but not men, every s.d. increment increase of total n−3 PUFAs and docosahexaenoic acid (DHA) was associated with lower mobility disability risk, odds ratio 0.48 (0.25; 0.93) and odds ratio 0.45 (0.24; 0.83), respectively. There was no association between n−6 PUFAs and the risk of incident mobility disability or gait speed decline. Conclusions: Higher concentrations of n−3 PUFAs and, particularly, DHA may protect women from impaired mobility but does not appear to have such an effect in men.
    European journal of clinical nutrition 01/2015; 69(4). DOI:10.1038/ejcn.2014.277 · 2.71 Impact Factor
Show more